By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Pew PatriotsPew PatriotsPew Patriots
Notification Show More
Font ResizerAa
  • Home
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Reading: Moderna Shares Crash On Sluggish COVID Demand, Cuts 2025 Revenue Forecast
Share
Font ResizerAa
Pew PatriotsPew Patriots
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Search
  • Home
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Have an existing account? Sign In
Follow US
Moderna Shares Crash On Sluggish COVID Demand, Cuts 2025 Revenue Forecast
Prepping & Survival

Moderna Shares Crash On Sluggish COVID Demand, Cuts 2025 Revenue Forecast

Jimmie Dempsey
Last updated: January 13, 2025 11:35 pm
Jimmie Dempsey Published January 13, 2025
Share
SHARE

This article was originally published by Tyler Durden at ZeroHedge. 

Shares of Moderna crashed in premarket trading after the company issued business and pipeline updates revealing sluggish demand for its Covid-19 and RSV vaccines. The weak sales environment forced the company to slash its 2025 full-year forecast, falling short of Wall Street’s average estimates.

Moderna released business updates and progress across its pipeline of mRNA medicines, plus outlooks on sales ahead of its presentation at the 43rd Annual JPMorgan Healthcare Conference at 3:45 PM.

The first disappointing update from the Cambridge, Massachusetts-based company was a downgraded sales forecast for 2025, which fell short of the average analyst estimate tracked by Bloomberg:

  • Sees revenue $1.5 billion to $2.5 billion, saw $2.5 billion to $3.5 billion, estimate $2.92 billion (Bloomberg Consensus)

“In 2024, we achieved $3.0 – 3.1 billion in product sales, approval of our RSV vaccine and continued to adapt our COVID-19 business for the endemic setting,” Moderna CEO Stéphane Bancel wrote in a press release.

Bancel continued, “At the same time, we reduced our cash operating cost by over 25 percent compared to 2023 and aim to reduce 2025 cash costs by $1 billion with a plan for an additional $500 million cost savings in 2026. We remain focused on our three strategic priorities: driving sales growth, delivering up to 10 product approvals over the next three years, and reducing costs across our business.”

Moderna’s post-pandemic future remains highly uncertain.

In September, the company revealed new plans to slash $1.1 billion in expenses by 2027 to steer toward profitability as the vaccine slump was gathering pace.

Investors were spooked by Moderna’s news. Shares in New York crashed as much as 20% in premarket trading. Shares have roundtripped the pandemic, trading around the $34 handle.

Meanwhile, Moderna is bracing for vast uncertainties as President-elect Donald Trump is just one week away from stepping into the White House. What keeps the CEO up at night is the top health nominee, Robert F. Kennedy Jr., a longtime vaccine critic.

To note: Moderna has the next pandemic covered: “U.S. Government Awards Moderna $176 Million Bird Flu Vaccine Contract” … 

Read the full article here

You Might Also Like

Elon Musk At Milken Conference: AI Will Replace Bloated, Inefficient Federal Gov’t

The Tragedy of War

Elon Musk: “USAID, Using YOUR Tax Dollars, Funded Bioweapon Research”

Computer Scientist Warns That Artificial Intelligence Could Turn Against Humanity

China Calls US Tariff Exemptions A “Small Step” Toward Fixing “Wrong Practice”

Share This Article
Facebook Twitter Email Print
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

We Recommend
Southern states join forces to break free from ‘woke accreditation cartels’
News

Southern states join forces to break free from ‘woke accreditation cartels’

Jimmie Dempsey Jimmie Dempsey June 27, 2025
11 Signs That The Entire Country Is Facing Enormous Economic Challenges Right Now
Trump’s crackdown nets over 2,700 alleged members of notorious Venezuelan gang
Venezuelan opposition member details harrowing 400-day captivity at UN
Sole survivors in Lake Tahoe boating disaster had one thing in common
No ‘significant’ mover capacity problems expected for troops, DOD says
Production AUX MFG Pocket Rocket Lands Through Boker
Guns and Gear

Production AUX MFG Pocket Rocket Lands Through Boker

Jimmie Dempsey Jimmie Dempsey June 27, 2025
Fox News Politics Newsletter: SCOTUS Reins in District Courts on Injunctions
News

Fox News Politics Newsletter: SCOTUS Reins in District Courts on Injunctions

Jimmie Dempsey Jimmie Dempsey June 27, 2025
US Air Force to retire all A-10s, cancel E-7 under 2026 spending plan
Tactical

US Air Force to retire all A-10s, cancel E-7 under 2026 spending plan

Jimmie Dempsey Jimmie Dempsey June 27, 2025
Pew Patriots
  • News
  • Tactical
  • Prepping & Survival
  • Videos
  • Guns and Gear
2024 © Pew Patriots. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?